Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EUCR

Eucrates Biomedical Acquisition (EUCR) Stock Price, News & Analysis

Eucrates Biomedical Acquisition logo

About Eucrates Biomedical Acquisition Stock (NASDAQ:EUCR)

Advanced Chart

Key Stats

Today's Range
$10.02
$10.04
50-Day Range
$10.04
$10.25
52-Week Range
$9.87
$10.25
Volume
12,700 shs
Average Volume
2,287 shs
Market Capitalization
$42.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Receive EUCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eucrates Biomedical Acquisition and its competitors with MarketBeat's FREE daily newsletter.

EUCR Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
8-K: Eucrates Biomedical Acquisition Corp.
See More Headlines

EUCR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Eucrates Biomedical Acquisition investors own include Sprott Focus Trust (FUND), Barrick Gold (GOLD), Meta Platforms (META), ETFMG Alternative Harvest ETF (MJX), New Zealand Energy (NZ), Strathcona Resources (SCR) and Shopify (SHOP).

Company Calendar

Today
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:EUCR
Web
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.81 per share
Price / Cash Flow
12.36
Book Value
($1.25) per share
Price / Book
-8.03

Miscellaneous

Free Float
3,386,000
Market Cap
$42.27 million
Optionable
Not Optionable
Beta
-0.07
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:EUCR) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners